Maple Leaf Green World Inc. (“Maple Leaf” or the “Company”) (TSX-V:MGW) (OTCQB:MGWFF) is pleased to announce that its application to become a licenced producer under the Access to Cannabis for Medical Purposes Regulations (the “ACMPR”) has progressed to “active review” status.
Maple Leaf Green World Inc. (“Maple Leaf” or the “Company”) (TSX-V:MGW) (OTCQB:MGWFF) is pleased to announce that its application to become a licenced producer under the Access to Cannabis for Medical Purposes Regulations (the “ACMPR”) has progressed to “active review” status. In the “active review” stage, the Company’s ACMPR application for the Company’s proposed cannabis cultivation facility to be located in Telkwa, British Columbia (the “Telkwa Facility”) will be thoroughly reviewed by Health Canada. The Company anticipates receiving requests for information and will be ready to participate in active communications with the Office of Medical Cannabis of Health Canada for additional information and clarifications to support Maple Leaf’s ACMPR application.
The “active review” stage precedes the issuance of a licence to produce. Upon completion of both the review and the security clearance process, the Company anticipates receiving a confirmation of readiness letter to demonstrate compliance with all the provisions of the ACMPR and the security directive. In order to confirm readiness, the Company will be required to submit information including documentation, photos, and videos of the Telkwa Facility and building plans showing evidence of all physical security measures.
For the latest photos of the Telkwa Facility and further information regarding the Company, please visit www.mlgreenworld.com.
About Maple Leaf Green World Inc.
Maple Leaf is a public Canadian company that focuses on the cannabis industry in North America. The Company currently operates cannabis projects in British Columbia and Nevada. With over ten years of extensive greenhouse management experience, the Company applies its eco-agriculture knowledge and cultivation technology to produce contaminant-free organic cannabis products. Maple Leaf’s long-term objective is to produce cannabis oil and to export its products to approved countries. The Company’s common shares are listed for trading on the TSXV under the symbol “MGW” and on the OTCQB market under the symbol “MGWFF”.
Certain statements in this press release are “forward-looking” statements within the meaning of Canadian securities legislation. All statements, other than statements of historical fact, included herein are forward-looking information. Forward-looking statements in this press release include, but are not limited to, the issuance of a licence to cultivate pursuant to the ACMPR and statements associated with the proposed Telkwa Facility. Forward-looking statements are generally, but not always, identified by the words “expects”, “plans”, “anticipates”, “in the event”, “if”, “believes”, “assets”, “position”, “intends”, “envisages”, “assumes”, “recommends”, “estimates”, “approximate”, “projects”, “potential”, “indicate” and similar expressions, or that events or conditions “will”, “would”, “may”, “could” or “should” occur. Forward-looking statements are necessarily based upon the current belief, opinions, and expectations of management that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political, and social uncertainties, and other contingencies. Many factors could cause the Company’s actual results to differ materially from those expressed or implied in the forward looking statements. These factors include, among others, delays in construction or in receiving materials to build the Telkwa Facility, and factors that would delay or change the Company’s ACMPR application, including the receipt of regulatory approvals and changes in legislation. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated, estimated, or intended. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company does not undertake to update any forward-looking statements or forward-looking information that are incorporated by reference herein, except in accordance with applicable securities laws. Investors are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty therein.
Although, the Company believes that expectations and assumptions reflected in the forward-looking information are reasonable, there can be no assurance that any forward-looking information will prove accurate, and actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. These forward-looking statements are made as of the date of this press release and the Company does not undertake to update any forward-looking information contained in this press release or that is incorporated by reference herein, whether as a result of new information, future events or results or otherwise, except in accordance with applicable securities laws.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.